English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function

MPS-Authors
/persons/resource/persons239399

Sokol,  Anna M.
Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons228784

Graumann,  Johannes
Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224044

Boettger,  Thomas
Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons248833

Richter,  Antje M.
Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Deutschmeyer, V., Breuer, J., Walesch, S. K., Sokol, A. M., Graumann, J., Bartkuhn, M., et al. (2019). Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function. CLINICAL EPIGENETICS, 11(1): 182. doi:10.1186/s13148-019-0774-2.


Cite as: http://hdl.handle.net/21.11116/0000-0006-AF11-2
Abstract
There is no abstract available